Correlation of the expression levels of BLyS and its receptors mRNA in patients with systemic lupus erythematosus

Clinical Biochemistry

Volumn 39, Issue 12, 2006, Pages 1131-1137

  Ju, Shaoqing ^a   Zhang, Donglei ^b   Wang, Yueguo ^b   Ni, Hongbing ^b   Kong, Xiantao ^a   Zhong, Renqian ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b NANTONG UNIVERSITY   (China)

Author keywords

Anti double stranded DNA; B lymphocyte stimulator; Real time PCR; Receptors; SLE disease activity index; Systemic lupus erythematosus

Indexed keywords

B CELL ACTIVATING FACTOR RECEPTOR; B CELL MATURATION ANTIGEN; B LYMPHOCYTE ANTIGEN; B LYMPHOCYTE STIMULATOR; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; CURVED DNA; DOUBLE STRANDED DNA ANTIBODY; INTERLEUKIN 4 ANTIBODY; LYMPHOCYTE ANTIGEN RECEPTOR; MESSENGER RNA; PLASMID DNA; PRIMER RNA; TRANSMEMBRANE ACTIVATOR AND CALCIUM MODULATOR CYCLOPHILIN LIGAND INTERACTOR;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENHANCER REGION; FEMALE; GENE EXPRESSION; GENE PROBE; HUMAN; HUMAN CELL; MALE; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMID; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; B-CELL ACTIVATING FACTOR; CLONING, MOLECULAR; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER;

EID: 33751502815     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2006.09.010     Document Type: Article

References (36)

1. Moore P.A., Belvedere O., Orr A., et al. BLyS: member of the tumour necrosis factor family and B lymphocyte stimulator. Science 285 (1999) 260-263
2. Schneider P., MacKay F., Steiner V., et al. BAFF, a novel ligand of the tumour necrosis factor family, stimulates B cell growth. J. Exp. Med. 189 (1999) 1747-1756
3. Mukhopadhyay A., Ni J., Zhai Y., et al. Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinase. J. Biol. Chem. 274 (1999) 15978-15981
4. Shu H.B., Hu W.H., and Johnson H. TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. J. Leukoc. Biol. 65 (1999) 680-683
5. Tribouley C., Wallroth M., Chan V., et al. Characterization of a new member of the TNF family expressed on antigen presenting cells. Biol. Chem. 380 (1999) 1443-1447
6. Kawasaki A., Tsuchiya N., Fukazawa T., et al. Presence of four major haplotypes in human BCMA gene: lack of association with systemic lupus erythematosus and rheumatoid arthritis. Genes Immun. 2 (2001) 276-279
7. Gross J.A., Johnston J., Mudri S., et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404 (2000) 995-999
8. Mackay F., Woodcock S.A., Lawton P., et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190 (1999) 1697-1710
9. Khare S.D., Sarosi I., Xia X.Z., et al. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 3370-3375
10. Thompson J.S., Schneider P., Kalled S.L., et al. BAFF binds to the tumor necrosis factor receptorlike molecule B cell maturation antigen and is important for maintaining the peripheral B cell population. J. Exp. Med. 192 (2000) 129-135
11. Thompson J.S., Bixler S.A., Qian F., et al. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 293 (2001) 2108-2111
12. Yan M., Brady J.R., Chan B., et al. Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency. Curr. Biol. 11 (2001) 1547-1552
13. Hsu B.L., Harless S.M., Hilbert D.M., et al. Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators [J]. J. Immunol. 168 (2002) 5993-5996
14. Batten M., Groom J., Cachero T.G., et al. BAFF mediates survival of peripheral immature B lyphocytes [J]. J. Exp. Med. 192 (2000) 1453-1465
15. Seshasayee D., Valdez P., Yan M., et al. Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor. Immunity 18 (2003) 279-288
16. Yan M., Wang H., Chan B., et al. Activation and accumulation of B cells in TACI-deficient mice. Nat. Immunol. 2 (2001) 638-643
17. Cheema G.S., Roschke V., Hilbert D.M., et al. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum. 44 (2001) 1313-1319
18. Yu G., Boone T., Delaney J., et al. APRIL and TALL-1 and receptor BCMA and TACI: system for regulating humoral immunity. Nat. Immunol. 1 (2000) 252-256
19. Stohl W., Brady J.R., Chan B., et al. Systemic lupus erythematosus: a blissless disease of too much BLyS (B lymphocyte stimulator) protein. Curr. Opin. Rheumatol. 14 (2002) 522-528
20. Stohl W., Metyas S., Tan S.M., et al. B Lymphocyte stimulator overexpression in patients with systemic lupus erythematosus. Arthritis Rheum. 48 (2003) 3475-3486
21. Mariette X., Roux S., Zhang J., et al. The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome. Ann. Rheum. Dis. 62 (2003) 168-171
22. Krumbholz M., Theil D., Derfuss T., et al. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J. Exp. Med. 201 (2005) 195-200
23. Novak A.J., Darce J.R., Arendt B.K., et al. Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival. Blood 103 (2004) 689-694
24. Briones J., Timmerman J.M., Hilbert D.M., et al. BLyS and BLyS receptor expression in non-Hodgkin's lymphoma. Exp. Hematol. 30 (2002) 135-141
25. Rodriguez B., Valdez H., Freimuth W., et al. Plasma levels of B-lymphocyte stimulator increase with HIV disease progression. AIDS 17 (2003) 1983-1985
26. Holland P.M., Abramson R.D., Watson R., et al. Detection of specific polymerase chain reaction product by utilizing the 5′-3′ exonoclease activity of thermus aquaticus DNA polymerase. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 7276-7280
27. Heid C.A., Stevens J., Livak K.J., et al. Real time quantitative PCR. Genome Res. 6 (1996) 986-994
28. Tan E.M., Cohen A.S., Fries J.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25 (1982) 1271-1277
29. Bombardier C., Gladman D.D., Urowitz M.B., et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum. 35 (1992) 630-640
30. Kotzin B.L. Systemic lupus erythematosus. Cell 85 (1996) 303-306
31. Zhang J., Roschke V., Baker K.P., et al. Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J. Immunol. 166 (2000) 6-10
32. Collins C.E., Gavin A.L., Migone T.S., et al. B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels. Arthritis Res. Ther. 8 15 (2005) R6. http://arthritis-research.com/content/8/1/R6 [Available online http://arthritis-research.com/content/8/1/R6]
33. Carter R.H., Zhao H., Liu X., et al. Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus. Arthritis Rheum. 52 (2005) 3943-3954
34. Novak A.J., Grote D.M., Stenson M., et al. Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome. Blood 104 8 (2004) 2247-2253
35. Tarte K., Zhan F., De Vos J., et al. Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation. Blood 102 (2003) 592-600
36. Avery D.T., Kalled S.L., Ellyard J.I., et al. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. J. Clin. Invest. 112 (2003) 286-297